What does spark therapeutics do?
Sommario
- What does spark therapeutics do?
- Who is spark Therapeutics owned by?
- Is spark Therapeutics publicly traded?
- What is the stock symbol for Spark Therapeutics?
- Is spark Therapeutics a good company to work for?
- Is spark Therapeutics part of Roche?
- What happened to spark Therapeutics stock?
- Is spark a Roche company?
- What is the share value of Oneplus?
- How many employees does spark therapeutics have?
- Why Spark Therapeutics?
- What is ionspark Therapeutics?
- Who is the co-founder of spark?
What does spark therapeutics do?
At Spark Therapeutics, a fully integrated, commercial company committed to discovering, developing and delivering gene therapies, we challenge the inevitability of genetic diseases, including blindness, hemophilia, lysosomal storage disorders and neurodegenerative diseases.
Who is spark Therapeutics owned by?
Hoffmann-La Roche Spark Therapeutics
| Type | Subsidiary of Hoffmann-La Roche |
|---|---|
| Number of employees | 368 (2019) |
| Parent | Hoffmann-La Roche |
| Website | sparktx.com |
| Footnotes / references |
Is spark Therapeutics publicly traded?
30, 2015 /PRNewswire/ — Spark Therapeutics announced today the pricing of its initial public offering of 7,000,000 shares of common stock at a public offering price of $23.00 per share, before underwriting discounts. ...
What is the stock symbol for Spark Therapeutics?
What is Spark Therapeutics' stock symbol? Spark Therapeutics trades on the NASDAQ under the ticker symbol "ONCE."
Is spark Therapeutics a good company to work for?
Excellent company to work for Friendly and collaborative colleagues and supportive management team. Leadership truly cares about employee engagement and workplace satisfaction. Ranked as one of the top employers by Science Magazine's Top Employers Survey.
Is spark Therapeutics part of Roche?
Spark Therapeutics will continue to operate as an independent company within the Roche Group. ... Marrazzo, co-founder and CEO of Spark Therapeutics. “Spark and Roche share an ethos of imagining the unimaginable. Together, we have the potential to change the future of medicine and deliver the medicines of tomorrow today.
What happened to spark Therapeutics stock?
Roche entered into an agreement to buy Spark (NASDAQ: ONCE) in February. ... Spark — which has grown to more than 450 employees — will continue to be based in Philadelphia and operate as a wholly owned subsidiary of Roche. Spark's shares will cease to be traded on the NASDAQ Stock Market.
Is spark a Roche company?
Spark Therapeutics will continue to operate as an independent company within the Roche Group. “Today ushers in a new and promising era in the development of genetic medicines for patients and families living with inherited diseases and beyond,” said Jeffrey D.
What is the share value of Oneplus?
Detailed Quotes
| Exchange & Time | NSE 24-Dec-2021 |
|---|---|
| Last Price | 79.00 |
| 1-D Change (%) | 1.80 |
| Open | 80.00 |
| Prev Close | 77.60 |
How many employees does spark therapeutics have?
Company Growth (employees)
| Employees (est.) (Feb 2019) | 368 | (+17%) |
|---|---|---|
| Job Openings | 88 | |
| Website Visits (Sept 2021) | 73.3 k | |
| Revenue (FY, 2018) | $64.7 M | (+437%) |
| Share Price (Dec 2019) | $113.6 |
Why Spark Therapeutics?
- Our mission at Spark Therapeutics is to challenge the inevitability of genetic disease by discovering, developing and delivering potential treatments in ways unimaginable—until now.
What is ionspark Therapeutics?
- Spark Therapeutics, Inc. is a developer of gene therapy treatments, which treat debilitating genetic diseases. It is a subsidiary of Hoffmann-La Roche .
Who is the co-founder of spark?
- In February 2020, Spark co-founder Katherine A. High stepped down from the company after the acquisition by Swiss pharma Roche.
